Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcutis Biotherapeutics (ARQT) Current Leases (2020 - 2025)

Arcutis Biotherapeutics (ARQT) has 6 years of Current Leases data on record, last reported at $842000.0 in Q1 2025.

  • For Q1 2025, Current Leases rose 11.38% year-over-year to $842000.0; the TTM value through Mar 2025 reached $842000.0, up 11.38%, while the annual FY2024 figure was $820000.0, 11.56% up from the prior year.
  • Current Leases reached $842000.0 in Q1 2025 per ARQT's latest filing, up from $820000.0 in the prior quarter.
  • Across five years, Current Leases topped out at $842000.0 in Q1 2025 and bottomed at $306000.0 in Q3 2021.
  • Average Current Leases over 5 years is $662533.3, with a median of $695000.0 recorded in 2023.
  • Peak YoY movement for Current Leases: soared 856.25% in 2021, then increased 11.38% in 2025.
  • A 5-year view of Current Leases shows it stood at $433000.0 in 2021, then surged by 51.73% to $657000.0 in 2022, then rose by 11.87% to $735000.0 in 2023, then increased by 11.56% to $820000.0 in 2024, then grew by 2.68% to $842000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Current Leases were $842000.0 in Q1 2025, $820000.0 in Q4 2024, and $798000.0 in Q3 2024.